The DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.
Effect of medication adherence on clinical outcomes in type 2 diabetes: analysis of the SIMPLE study
Open accessAbstract
Objective: Medication adherence is impacted by regimen complexity. The SIMPLE (Simple basal Insulin titration, Metformin Plus Liraglutide for type 2 diabetes with very Elevated HbA1c) study compared GLP1RA plus basal insulin (GLP1RA+BI) to basal-bolus insulin (BBI) regimen in participants with very uncontrolled type 2 diabetes mellitus (T2DM). This analysis aimed to evaluate medication adherence to GLP1RA+BI compared with BBI, the effect of adherence on clinical and patient-reported outcomes, and baseline predictors of adherence. Research design and methods: This was an analysis of the SIMPLE study based on prespecified outcome. The study took place in pragmatic, real-world setting. A total of 120 adults with T2DM and HgbA1c≥10% were randomized to detemir plus liraglutide, or detemir plus aspart before each meal; 6-month follow-up. The main outcomes evaluated were: adherence, HgbA1c, weight, quality of life, and hypoglycemia. Adherence rate was calculated for each study medication at each follow-up visit; participants were classified as ≥80% or <80% adherent. Result: A higher percentage of participants in the GLP1RA+BI compared with the BBI group had ≥80% adherence to detemir (59.3% vs 35.7%, p=0.02) as well as liraglutide versus aspart (57.4% vs 30.4%, p=0.007). Higher age was predictive of ≥80% adherence (OR per 5-year increment=1.48, 95% CI 1.09 to 2.0, p=0.01). Higher adherence led to greater improvement in HbA1c and weight in both groups. Treatment with GLP1RA+BI compared with BBI led to greater improvement in HbA1c, weight, and quality of life and lower risk of hypoglycemia even after adjusting for the difference in adherence between groups. Conclusions: Adherence was higher with the simplified regimen of GLP1RA+BI compared with BBI. Greater adherence to the simpler regimen amplified the treatment effect on HbA1c, weight, quality of life, and risk of hypoglycemia, yet statistically significant greater benefits were noted even when adjusted for adherence. Trial registration number: NCT01966978
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Restrictive conditions for the intake of oral medications may adversely affect treatment adherence and compliance and, consequently, patient outcomes [23,24].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adherence to Therapies in Patients with Type 2 Diabetes
García-Pérez, L.-E., Álvarez, M., Dilla, T., Gil-Guillén, V., & Orozco-Beltrán, D. (2013) · Diabetes Therapy · doi:10.1007/s13300-013-0034-y · Cited by 726
Comparing Adherence and Persistence Across 6 Chronic Medication Classes
Yeaw, J., Benner, J. S., Walt, J. G., Sian, S., & Smith, D. B. (2009) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2009.15.9.728 · Cited by 549
Type 2 Diabetes in the Real World: The Elusive Nature of Glycemic Control
Edelman, S. V., & Polonsky, W. H. (2017) · Diabetes Care · doi:10.2337/dc16-1974 · Cited by 285
Adherence to insulin and its association with glycaemic control in patients with type 2 diabetes
Donnelly, L. A., Morris, A. D., Evans, J. M. M., & for the DARTS/MEMO collaboration (2007) · QJM · doi:10.1093/qjmed/hcm031 · Cited by 230
Billings, L. K., Doshi, A., Gouet, D., Oviedo, A., Rodbard, H. W., Tentolouris, N., Grøn, R., Halladin, N., & Jodar, E. (2018) · Diabetes Care · doi:10.2337/dc17-1114 · Cited by 193
Hertz, R. P., Unger, A. N., & Lustik, M. B. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.07.009 · Cited by 185
Abd El Aziz, M. S., Kahle, M., Meier, J. J., & Nauck, M. A. (2017) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12804 · Cited by 155
Carls, G. S., Tuttle, E., Tan, R.-D., Huynh, J., Yee, J., Edelman, S. V., & Polonsky, W. H. (2017) · Diabetes Care · doi:10.2337/dc16-2725 · Cited by 153
Rosenstock, J., Guerci, B., Hanefeld, M., Gentile, S., Aronson, R., Tinahones, F. J., Roy-Duval, C., Souhami, E., Wardęcki, M., Ye, J., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0014 · Cited by 136
Spain, C. V., Wright, J. J., Hahn, R., Wivel, A. E., & Martin, A. A. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.05.009 · Cited by 121
Cited by
Diagnosis, treatment and prevention of type 2 diabetes mellitus in children and adolescents
Serbis, A., Giapros, V. I., Kotanidou, E. P., Galli‐Τsinopoulou, A., & Siomou, E. C. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i4.344 · Cited by 129
Psychosocial Determinants of Treatment Adherence in Patients with Type 2 Diabetes – A Review
Świątoniowska-Lonc, N., Tański, W., Polański, J., Jankowska‐Polańska, B., & Mazur, G. J. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s308322 · Cited by 129
Kellerer, M., Kaltoft, M. S., Lawson, J., Nielsen, L. L., Strojek, K., Tabak, Ö., & Jacob, S. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14765 · Cited by 107
“Goals include minimizing hypoglycaemia and weight gain, and reducing the risk of complications such as atherosclerotic cardiovascular (CV) disease.1,2 While some clinical guidelines recommend a glucagon-like peptide-1 receptor agonist (GLP-1RA) as the first injectable antihyperglycaemic during treatment intensificatio…”
BackgroundResultInfluentialKatsaridis, S., Grammatikopoulou, M. G., Gkiouras, K., Tzimos, C., Papageorgiou, S. Τ., Markaki, A. G., Exiara, T., Goulis, D. G., & Papamitsou, T. (2020) · Nutrients · doi:10.3390/nu12113516 · Cited by 43
“Concerning diet, studies have revealed an improved adherence rate with a more recent DM diagnosis (and subsequently, younger age) [53]; concerning medication, increasing age appears to ameliorate adherence [6,7,54,55].”
BackgroundChong, C. J., Makmor‐Bakry, M., Hatah, E., Tahir, N. A. M., & Mustafa, N. (2023) · Journal of Telemedicine and Telecare · doi:10.1177/1357633x231174933 · Cited by 40
“52,53 Our meta-analysis has highlighted the bene fi cial effects of mobile apps intervention on glycaemic outcomes, postulating that reduction of HbA1c was a result of improved adherence.”
Metadata
- Authors
- Patel, S., Abreu, M., Tumyan, A., Adams-Huet, B., Li, X., & Lingvay, I.
- Affiliations
- Endocrinology, Diabetes and Metabolism, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Lingvay, Ildiko
- Venue
- BMJ Open Diabetes Research & Care
- Publisher
- BMJ
- Published
- 2019-11
- Volume
- 7
- Issue
- 1
- Pages
- e000761
- ISSN
- 2052-4897 (ISSN-L)
- PMC
- PMC6887507
- OpenAlex
- W2990909872
- Cited by
- 56
- References
- 28
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 11 · 2023: 9 · 2022: 10 · 2021: 9 · 2020: 3
- FWCI
- 5.66
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- BMJ Open Diabetes Research & Care (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Novo Nordisk
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- medication adherence, type 2 diabetes, GLP-1 receptor agonists, liraglutide, basal insulin, detemir, multiple daily insulin injections, HbA1c, weight, quality of life, hypoglycemia, predictors of adherence, patient-reported outcomes, real-world evidence, pragmatic trials
- MeSH terms
- Liraglutide, Blood Glucose, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Insulin, Male, Metformin, Middle Aged, Prognosis, Prospective Studies, Quality of Life, Biomarkers, Drug Monitoring, Medication Adherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of medication adherence on clinical outcomes in type 2 diabetes: analysis of the SIMPLE study. https://app.cochat.ai/papers/10.1136/bmjdrc-2019-000761
- The paper
- Patel, S., Abreu, M., Tumyan, A., Adams-Huet, B., Li, X., & Lingvay, I. (2019). Effect of medication adherence on clinical outcomes in type 2 diabetes: analysis of the SIMPLE study. BMJ Open Diabetes Research & Care. https://doi.org/10.1136/bmjdrc-2019-000761
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.